10913-2 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine | 4,4'-Methylene bis(2-Chloroaniline) |
38746-4 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Air | 4,4'-Methylene bis(2-Chloroaniline) |
48137-4 | 4,5-Dihydroxyhexanoate/Creatinine [Molecular ratio] in Urine | 4,5-Dihydroxyhexanoate/Creatinine |
48106-9 | 4,5-Dihydroxyhexanolactone/Creatinine [Molecular ratio] in Urine | 4,5-Dihydroxyhexanolactone/Creatinine |
38690-4 | 4,6-Dinitro-O-Cresol [Mass/volume] in Air | 4,6-Dinitro-O-Cresol |
38632-6 | 4-Biphenylamine [Mass/volume] in Air | 4-Biphenylamine |
47823-0 | 4-Hydroxy-3-Methoxyphenyllactate/Creatinine [Molecular ratio] in Urine | 4-Hydroxy-3-Methoxyphenyllactate/Creatinine |
43732-7 | 4-Hydroxybenzoate [Presence] in Urine | 4-Hydroxybenzoate |
43733-5 | 4-Hydroxybenzoate [Presence] in 24 hour Urine | 4-Hydroxybenzoate |
47541-8 | 4-Hydroxybenzoate/Creatinine [Molecular ratio] in Urine | 4-Hydroxybenzoate/Creatinine |
51189-9 | 4-Hydroxybupivacaine [Mass/volume] in Serum or Plasma | 4-Hydroxybupivacaine |
29869-5 | 4-Hydroxycyclohexylacetate [Presence] in Urine | 4-Hydroxycyclohexylacetate |
13544-2 | 4-Hydroxyglutethimide [Presence] in Serum or Plasma | 4-Hydroxyglutethimide |
35637-8 | 4-Hydroxyglutethimide [Mass/volume] in Serum or Plasma by Screen method | 4-Hydroxyglutethimide |
50293-0 | 4-Hydroxyifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide | 4-Hydroxyifosfamide^1D post dose ifosfamide |
50294-8 | 4-Hydroxyifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide | 4-Hydroxyifosfamide^2D post dose ifosfamide |
50295-5 | 4-Hydroxyifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide | 4-Hydroxyifosfamide^3D post dose ifosfamide |
50298-9 | 4-Hydroxyifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide | 4-Hydroxyifosfamide^3H post dose ifosfamide |
50296-3 | 4-Hydroxyifosfamide [Mass/volume] in Blood --4D post dose ifosfamide | 4-Hydroxyifosfamide^4D post dose ifosfamide |
50297-1 | 4-Hydroxyifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide | 4-Hydroxyifosfamide^5D post dose ifosfamide |
50299-7 | 4-Hydroxyifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide | 4-Hydroxyifosfamide^6H post dose ifosfamide |
50292-2 | 4-Hydroxyifosfamide [Mass/volume] in Blood --pre dose ifosfamide | 4-Hydroxyifosfamide^pre dose ifosfamide |
44861-3 | 4-Hydroxymandelate/Creatinine [Mass ratio] in Urine | 4-Hydroxymandelate/Creatinine |
47543-4 | 4-Hydroxymandelate/Creatinine [Molecular ratio] in Urine | 4-Hydroxymandelate/Creatinine |
27270-8 | 4-Hydroxyphenylacetate [Presence] in Urine | 4-Hydroxyphenylacetate |
13696-0 | 4-Hydroxyphenylacetate/Creatinine [Mass ratio] in Urine | 4-Hydroxyphenylacetate/Creatinine |
25088-6 | 4-Hydroxyphenylacetate/Creatinine [Molecular ratio] in Urine | 4-Hydroxyphenylacetate/Creatinine |
28585-8 | 4-Hydroxyphenylacetate/Creatinine [Ratio] in Urine | 4-Hydroxyphenylacetate/Creatinine |
29870-3 | 4-Hydroxyphenyllactate [Presence] in Urine | 4-Hydroxyphenyllactate |
13697-8 | 4-Hydroxyphenyllactate/Creatinine [Mass ratio] in Urine | 4-Hydroxyphenyllactate/Creatinine |
25089-4 | 4-Hydroxyphenyllactate/Creatinine [Molecular ratio] in Urine | 4-Hydroxyphenyllactate/Creatinine |
28586-6 | 4-Hydroxyphenyllactate/Creatinine [Ratio] in Urine | 4-Hydroxyphenyllactate/Creatinine |
29871-1 | 4-Hydroxyphenylpyruvate [Presence] in Urine | 4-Hydroxyphenylpyruvate |
13698-6 | 4-Hydroxyphenylpyruvate/Creatinine [Mass ratio] in Urine | 4-Hydroxyphenylpyruvate/Creatinine |
29519-6 | 4-Hydroxyphenylpyruvate/Creatinine [Molecular ratio] in Urine | 4-Hydroxyphenylpyruvate/Creatinine |
1688-1 | 4-Pyridoxate [Mass/volume] in Serum or Plasma | 4-Pyridoxate |
35586-7 | 4-Tert-Butylphenol [Mass/volume] in Urine | 4-Tert-Butylphenol |
42059-6 | None | 4th course treatment.biological response modifier therapy |
42057-0 | None | 4th course treatment.chemotherapy |
42058-8 | None | 4th course treatment.hormonal therapy |
42060-4 | None | 4th course treatment.other therapy |
42056-2 | None | 4th course treatment.radiation |
42055-4 | None | 4th course treatment.surgery |